Residents across Buffalo and the greater Western New York region are being advised to check their medicine cabinets following a nationwide recall of Xanax XR (alprazolam). The U.S. Food and Drug Administration (FDA) recently announced that pharmaceutical manufacturer Viatris Specialty LLC is pulling a specific lot of the popular anxiety medication from pharmacy shelves due to concerns over drug efficacy.
The Technical Failure: Why the Recall Matters
The recall was triggered after the medication failed to meet critical “dissolution requirements.” In investigative terms, dissolution testing is the process that determines how quickly and effectively a pill breaks down in the body to release its active ingredients. When a drug like alprazolam extended-release fails these tests, it means the medication may not be absorbed at the intended rate, potentially leading to an incorrect dosage or reduced effectiveness for the patient.
For individuals in our community managing panic disorders or generalized anxiety, consistent dosing is vital. A failure in the time-release mechanism of an extended-release tablet can disrupt treatment plans and lead to unexpected symptoms.
Identifying the Affected Product
The recall specifically targets one lot of 3 mg extended-release tablets. While the distribution was nationwide, including many local pharmacies throughout Erie and Niagara counties, only one specific batch is currently under scrutiny.
| Product Detail | Information |
|---|---|
| Medication | Xanax XR (alprazolam) 3 mg |
| Packaging | 60-tablet bottles |
| Lot Number | #8177156 |
| Expiration Date | February 28, 2027 |
| Distribution Dates | August 27, 2024, to May 29, 2025 |
The FDA has categorized this as a Class II recall. This classification suggests that while the product may cause temporary or medically reversible adverse health consequences, the probability of serious harm is considered remote. To date, there have been no confirmed reports of adverse reactions specifically linked to this lot.
Steps for Western New York Patients
If you or a family member are currently prescribed Xanax XR, the Lake Erie Times recommends taking the following steps immediately:
- Check the Bottle: Verify the Lot Number (#8177156) and expiration date on your prescription container.
- Consult Your Pharmacist: Local pharmacies in the Buffalo area are aware of the recall and can help verify if your specific fill was part of the affected batch.
- Do Not Abruptly Stop: Medical professionals warn against stopping benzodiazepines suddenly, as this can lead to withdrawal symptoms. Contact your healthcare provider to discuss a replacement or alternative treatment.
William Strasmore, reporting for the Lake Erie Times, continues to monitor regional impacts of national pharmaceutical recalls. Our mission is to provide the Western New York community with accurate, in-depth, and engaging news coverage, fostering informed dialogue and strengthening connections within our region.
About Lake Erie Times: Lake Erie Times is your comprehensive source for the latest news, insights, and stories from Buffalo, New York, and the broader Western New York region. Stay connected with our local news, community updates, and lifestyle coverage.
Reporting by William Strasmore: William is a dedicated news reporter in Western New York who delivers in-depth, impartial coverage on local issues. For more of his investigative work, visit his author page.
Disclaimer: The content provided by Lake Erie Times is for informational purposes only and should not be considered as professional medical, legal, or financial advice. Affiliate Disclaimer: Some links on Lake Erie Times are affiliate links. This means that if you make a purchase through these links, we may earn a commission at no additional cost to you.
